Quanta Therapeutics Raises Over $50 Million In Series D Financing To Advance Its Pipeline Of Kras Inhibitors
Amount Raised
$50 Million
Round Type
Series D
San FranciscoBiotechnologyDescription
Quanta Therapeutics, a privately-held biopharmaceutical company pioneering targeted therapies to treat RAS-driven cancers, today announced a $50.7 million Series D financing. The financing was led by Avidity Partners and was supported by Quanta’s existing investors including Sofinnova Investments, Vida Ventures, Surveyor Capital (a Citadel company), Longitude Capital, BVF Partners and AbbVie Ventures. Other new participants were GC&H Investments (the partner fund of Cooley LLP) and WS Investment Company (Wilson Sonsini’s venture arm). The Series D funding brings the total amount raised since inception to over $142 million.
Quick answer
Quanta Therapeutics raised $50 Million in a Series D round, dated May 22, 2023. Quanta Therapeutics is based in San Francisco, California, United States.
- How much did Quanta Therapeutics raise?
- Quanta Therapeutics raised $50 Million in a Series D round on May 22, 2023.
- What does Quanta Therapeutics do?
- Quanta Therapeutics is a private biopharmaceutical company focused on the most prevalent and elusive target in oncology—RAS.
- Where is Quanta Therapeutics based and how big is it?
- Quanta Therapeutics is based in San Francisco, California, United States.
- Who are the decision-makers at Quanta Therapeutics?
- Fundz holds 1 contact at Quanta Therapeutics, including the Chief Business Officer and Chief Financial Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Quanta Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Caribou raised $25M on July 6, 2023.
- SpyGlass Pharma, Inc. raised $40M on July 6, 2023.
- Append Medical raised $4.3M (Series A) on July 6, 2023.
- TolerogenixX raised $13M (Series A) on July 6, 2023.
- Liquet Medical raised an undisclosed amount (Funding Round) on July 6, 2023.
- Ocelot Bio raised $3M on July 6, 2023.
Who to call at Quanta Therapeutics, and when
A new round usually means Quanta Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Quanta Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Quanta Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Quanta Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Quanta Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Quanta Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.